ANTIKÖRPER GEGEN CCR2

Patent europeic · EP2321351 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2321351
Numer da la dumonda
EP09789161
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-08-2009
Publitgà
18-05-2011
Concedì
01-11-2017
Stritgà
31-08-2018
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/00 (2006.01)
C07K 16/28 (2006.01)
Prioritad
US 189357 P 18.08.2008
Dumonda PCT
PCT/US2009/004711 17.08.2009
Publicaziun PCT
WO2010/021697 25.02.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-03-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.03.2019

  2. 01-11-2017

    Concedì

    Published in Swissreg on 01.11.2017

Partidas

Possessur

Pfizer Inc.

235 East 42nd Street, New York, NY 10017, US

Amgen Fremont Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Inventur

BELOUSKI, Shelley Sims

Thousand Oaks, California 91360, US

GREEN, Larry L.

San Francisco, California 94114, US

LIANG, Meina

Santa Clara, CA 95051, US

GLADUE, Ronald P.

Stonington Connecticut 06378, US

KELLER, Bradley T.

Chesterfield Missouri 63017, US

OGAWA, Shinji

Yoyogi, Shibuya-ku Tokyo 1518589, JP

RAJPAL, Arvind

San Francisco California 94127, US

TYLASKA, Laurie A.

Preston Connecticut 06365, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.